Profluent, GEMMABio, and ARPA-H ‘s 160 Million Base Editor Moonshot: Why the AI-Designed Editor Was Never the Bottleneck and the FDA’s Plausible Mechanism Pathway Is the Real Bet
ARPA-H just put $160M behind seven teams to advance personalized genetic medicines.
Read the full articleYou might also wanna read
STAT+: ARPA-H launches $160 million effort to develop custom gene editing drugs
An ARPA-H program to jump-start custom gene editing treatments was delayed by a change in administrations. Now seven labs will get sizable g
ARPA-H awards up to $160M to scientists developing custom genetic medicines
The Advanced Research Projects Agency for Health has awarded a new tranche of funds for companies and institutions developing personalized g
ARPA-H Awards $43M to Philadelphia Researchers to Advance Scalable Genetic Medicines for Rare Diseases
July 9, 2026 — The U.S. government has awarded $43 million to Philadelphia-based researchers through a new federal effort to advance scalabl
Jackson Laboratory and Broad Institute receive $34.5M ARPA-H award for pediatric epilepsy gene editing platform
Pediatric Epilepsies & Rare CNS Gene Editing Platform (PERC) accelerates the development of precision genetic medicines for severe childhood
jax.org·7d agoRecursive Superintelligence Raises $650M to Build AI That Rewrites Itself — Here's the Actual Plan
Eight co-founders who collectively built the Vision Transformer, Meta FAIR's RL research, and OpenAI's open-endedness work raised $650M at a
Popular Open Source AI Developer Tool Ollama Raises $65M, Grows to Nearly 9M Users
Benchmark-backed Ollama has amassed 176,000 stars, and nearly 17,000 forks on GitHub by helping developers easily run AI on their PCs.
Comments
Sign in to join the conversation.
No comments yet. Be the first.